ImmuPhar - IUPhar Immunopharmacology Section,
#CTA_Journal published the first in man, proof of concept phase II trial study results on “#Allergy #immunotherapy with a…
#CTA_Journal published the first in man, proof of concept phase II trial study results on “#Allergy #immunotherapy with a…
#CTA_Journal published the first in man, proof of concept phase II trial study results on “#Allergy #immunotherapy with a…
„#Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial…